Aptevo Therapeutics is a biotech company primarily focused on bringing novel oncology and hematology therapeutics to market.
Aptevo Therapeutics's investors include Niowave, Yorkville Advisors.
Aptevo Therapeutics is headquartered in Seattle, United States.
Aptevo Therapeutics is a biotech company primarily focused on bringing novel oncology and hematology therapeutics to market.
Aptevo Therapeutics is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Aptevo Therapeutics — Funding & Investors." VCBacked, May 27, 2026, https://www.vcbacked.co/company/aptevo-therapeutics. Accessed October 3, 2026.
VCBacked. (2026). Aptevo Therapeutics — Funding & Investors. Retrieved October 3, 2026, from https://www.vcbacked.co/company/aptevo-therapeutics
{{cite web |title=Aptevo Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/aptevo-therapeutics |website=VCBacked |access-date=October 3, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated